New Federal Research Agenda Set for Drug-Resistant TB

The National Institute of Allergy and Infectious Diseases announced a new research agenda to fight drug-resistant tuberculosis in both of its forms -- multidrug-resistant (MDR) and extensively drug-resistant (XDR). Both "are occurring at an ominous and accelerating rate," according to the NIH agency's announcement. NIAID Director Dr. Anthony S. Fauci and members of the NIAID Tuberculosis Working Group created the agenda, which is available online in The Journal of Infectious Diseases.

"The TB diagnostic tools in use today are antiquated, slow, and insensitive; TB drug regimens are complex and lengthy; and the only vaccine available does not provide effective protection against adult pulmonary TB," said Fauci. "The challenge of TB control is further compounded by the rise of drug-resistant TB, and we anticipate that the NIAID Research Agenda for Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis will contribute substantively to the fight against this emerging threat."

The World Health Organization estimates 500,000 people worldwide have MDR-TB, while XDR-TB has been detected in 46 countries. Factors contributing to these increases include lack of routine testing to determine TB drug-sensitivity, incomplete treatment of people infected with TB-causing bacteria, an epidemic of TB in HIV-infected people, and limited TB research by pharmaceutical companies, the agency said.

The agenda identifies areas of biomedical research that are likely to contribute to a global public health response. The priorities include efforts to develop and test reliable technologies to rapidly diagnose TB and to identify drug resistance; define the most effective use of existing TB therapies and other antibiotics available to treat drug-resistant TB and develop new drugs, particularly to treat MDR-TB and XDR-TB; better understand the basic biology of TB-causing bacteria and their interaction with the human host that underlie the development of drug-resistant TB; understand the epidemiology of drug-resistant TB; investigate the various manifestations of TB in adults, children and those with co-infections, including HIV/AIDS; and conduct research to develop new vaccines and other preventive strategies.

Download Center

HTML - No Current Item Deck
  • Free Safety Management Software Demo

    IndustrySafe Safety Management Software helps organizations to improve safety by providing a comprehensive toolset of software modules to help businesses identify trouble spots; reduce claims, lost days, OSHA fines; and more.

  • The Top 5 Safety and Technology Trends to Watch in 2019

    Get the latest on trends you can expect to hear more about in 2019, including continued growth of mobile safety applications, wearable technology, and smart PPE; autonomous vehicles; pending OSHA recordkeeping rulemaking; and increased adoption of international safety standard, ISO 45001.

  • Get the Ultimate Guide to OSHA Recordkeeping

    OSHA’s Form 300A posting deadline is February 1! Are you prepared? To help answer your key recordkeeping questions, IndustrySafe put together this guide with critical compliance information.

  • Safety Training 101

    When it comes to safety training, no matter the industry, there are always questions regarding requirements and certifications. We’ve put together a guide on key safety training topics, requirements for certifications, and answers to common training questions.

  • Conduct EHS Inspections and Audits

    Record and manage your organization’s inspection data with IndustrySafe’s Inspections module. IndustrySafe’s pre-built forms and checklists may be used as is, or can be customized to better suit the needs of your organization.

  • Industry Safe

OH&S Digital Edition

  • OHS Magazine Digital Edition - January 2019

    January 2019

    Featuring:

    • PREVENTING ERRORS
      Production vs. Safety 
    • EMERGENCY SHOWERS & EYEWASH
      Meeting the Requirements for Emergency Equipment
    • CONSTRUCTION SAFETY
      The State of Contractor Safety
    • FOOT PROTECTION
      The Three Keys to Effective Chemical Management
    View This Issue